Description
Mazdutide is a clinical-stage dual agonist of the GLP-1 and glucagon receptors, derived from the oxyntomodulin template.
Published trial data explore weight, liver-fat and lipid endpoints, with the glucagon arm studied for its energy-expenditure contribution — positioning mazdutide in the same next-generation incretin research space as retatrutide and survodutide.
Format & handling
Supplied as a lyophilized powder in a sealed, batch-stamped vial. Store sealed at −20 °C protected from light. For laboratory work, reconstitute with bacteriostatic water shortly before use and refrigerate any working solution at 2–8 °C.
For laboratory research use only — not for human or veterinary use. The summary above describes published research for scientific context and makes no claims about this product.
